Global Oligonucleotide Therapeutics Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15083380 | Publishing Date : 14-Jan-2020 | No. of pages : 97
Detailed TOC of Global Oligonucleotide Therapeutics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oligonucleotide Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Oligonucleotide Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antisense Oligonucleotide
1.4.3 Aptamer
1.4.4 Other
1.5 Market by Application
1.5.1 Global Oligonucleotide Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Neuromuscular Diseases
1.5.3 ATTR
1.5.4 Hepatic VOD
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Oligonucleotide Therapeutics Market Perspective (2015-2026)
2.2 Oligonucleotide Therapeutics Growth Trends by Regions
2.2.1 Oligonucleotide Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Oligonucleotide Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Oligonucleotide Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Oligonucleotide Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Oligonucleotide Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Oligonucleotide Therapeutics Players by Market Size
3.1.1 Global Top Oligonucleotide Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Oligonucleotide Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Oligonucleotide Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Oligonucleotide Therapeutics Market Concentration Ratio
3.2.1 Global Oligonucleotide Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Oligonucleotide Therapeutics Revenue in 2019
3.3 Oligonucleotide Therapeutics Key Players Head office and Area Served
3.4 Key Players Oligonucleotide Therapeutics Product Solution and Service
3.5 Date of Enter into Oligonucleotide Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Oligonucleotide Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Oligonucleotide Therapeutics Forecasted Market Size by Type (2021-2026)
5 Oligonucleotide Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Oligonucleotide Therapeutics Market Size by Application (2015-2020)
5.2 Global Oligonucleotide Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Oligonucleotide Therapeutics Market Size (2015-2020)
6.2 Oligonucleotide Therapeutics Key Players in North America (2019-2020)
6.3 North America Oligonucleotide Therapeutics Market Size by Type (2015-2020)
6.4 North America Oligonucleotide Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Oligonucleotide Therapeutics Market Size (2015-2020)
7.2 Oligonucleotide Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Oligonucleotide Therapeutics Market Size by Type (2015-2020)
7.4 Europe Oligonucleotide Therapeutics Market Size by Application (2015-2020)
8 South America
8.1 South America Oligonucleotide Therapeutics Market Size (2015-2020)
8.2 Oligonucleotide Therapeutics Key Players in South America (2019-2020)
8.3 South America Oligonucleotide Therapeutics Market Size by Type (2015-2020)
8.4 South America Oligonucleotide Therapeutics Market Size by Application (2015-2020)
9 China
9.1 China Oligonucleotide Therapeutics Market Size (2015-2020)
9.2 Oligonucleotide Therapeutics Key Players in China (2019-2020)
9.3 China Oligonucleotide Therapeutics Market Size by Type (2015-2020)
9.4 China Oligonucleotide Therapeutics Market Size by Application (2015-2020)
10 Japan
10.1 Japan Oligonucleotide Therapeutics Market Size (2015-2020)
10.2 Oligonucleotide Therapeutics Key Players in Japan (2019-2020)
10.3 Japan Oligonucleotide Therapeutics Market Size by Type (2015-2020)
10.4 Japan Oligonucleotide Therapeutics Market Size by Application (2015-2020)
11Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview and Its Total Revenue
11.1.3 Biogen Oligonucleotide Therapeutics Introduction
11.1.4 Biogen Revenue in Oligonucleotide Therapeutics Business (2015-2020))
11.1.5 Biogen Recent Development
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Details
11.2.2 Sarepta Therapeutics Business Overview and Its Total Revenue
11.2.3 Sarepta Therapeutics Oligonucleotide Therapeutics Introduction
11.2.4 Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Business (2015-2020)
11.2.5 Sarepta Therapeutics Recent Development
11.3 Jazz Pharmaceuticals
11.3.1 Jazz Pharmaceuticals Company Details
11.3.2 Jazz Pharmaceuticals Business Overview and Its Total Revenue
11.3.3 Jazz Pharmaceuticals Oligonucleotide Therapeutics Introduction
11.3.4 Jazz Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2015-2020)
11.3.5 Jazz Pharmaceuticals Recent Development
11.4 Bausch & Lomb
11.4.1 Bausch & Lomb Company Details
11.4.2 Bausch & Lomb Business Overview and Its Total Revenue
11.4.3 Bausch & Lomb Oligonucleotide Therapeutics Introduction
11.4.4 Bausch & Lomb Revenue in Oligonucleotide Therapeutics Business (2015-2020)
11.4.5 Bausch & Lomb Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview and Its Total Revenue
11.5.3 Alnylam Pharmaceuticals Oligonucleotide Therapeutics Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2015-2020)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Dynavax Technologies
11.6.1 Dynavax Technologies Company Details
11.6.2 Dynavax Technologies Business Overview and Its Total Revenue
11.6.3 Dynavax Technologies Oligonucleotide Therapeutics Introduction
11.6.4 Dynavax Technologies Revenue in Oligonucleotide Therapeutics Business (2015-2020)
11.6.5 Dynavax Technologies Recent Development
11.7 Kastle therapeutics
11.7.1 Kastle therapeutics Company Details
11.7.2 Kastle therapeutics Business Overview and Its Total Revenue
11.7.3 Kastle therapeutics Oligonucleotide Therapeutics Introduction
11.7.4 Kastle therapeutics Revenue in Oligonucleotide Therapeutics Business (2015-2020)
11.7.5 Kastle therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview and Its Total Revenue
11.8.3 Akcea Therapeutics Oligonucleotide Therapeutics Introduction
11.8.4 Akcea Therapeutics Revenue in Oligonucleotide Therapeutics Business (2015-2020)
11.8.5 Akcea Therapeutics Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Oligonucleotide Therapeutics Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Oligonucleotide Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Oligonucleotide Therapeutics Revenue
Table 3. Ranking of Global Top Oligonucleotide Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Oligonucleotide Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antisense Oligonucleotide
Table 6. Key Players of Aptamer
Table 7. Key Players of Other
Table 8. Global Oligonucleotide Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Oligonucleotide Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Oligonucleotide Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Oligonucleotide Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Oligonucleotide Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Oligonucleotide Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Oligonucleotide Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Oligonucleotide Therapeutics Players
Table 19. Global Oligonucleotide Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Oligonucleotide Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Oligonucleotide Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide Therapeutics as of 2019)
Table 22. Global Oligonucleotide Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Oligonucleotide Therapeutics Product Solution and Service
Table 25. Date of Enter into Oligonucleotide Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oligonucleotide Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Oligonucleotide Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Oligonucleotide Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Oligonucleotide Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Oligonucleotide Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Oligonucleotide Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Oligonucleotide Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Oligonucleotide Therapeutics Market Share (2019-2020)
Table 35. North America Oligonucleotide Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Oligonucleotide Therapeutics Market Share by Type (2015-2020)
Table 37. North America Oligonucleotide Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Oligonucleotide Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Oligonucleotide Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Oligonucleotide Therapeutics Market Share (2019-2020)
Table 41. Europe Oligonucleotide Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Oligonucleotide Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Oligonucleotide Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Oligonucleotide Therapeutics Market Share by Application (2015-2020)
Table 45. South America Key Players Oligonucleotide Therapeutics Revenue (2019-2020) (Million US$)
Table 46. South America Key Players Oligonucleotide Therapeutics Market Share (2019-2020)
Table 47. South America Oligonucleotide Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. South America Oligonucleotide Therapeutics Market Share by Type (2015-2020)
Table 49. South America Oligonucleotide Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. South America Oligonucleotide Therapeutics Market Share by Application (2015-2020)
Table 51. China Key Players Oligonucleotide Therapeutics Revenue (2019-2020) (Million US$)
Table 52. China Key Players Oligonucleotide Therapeutics Market Share (2019-2020)
Table 53. China Oligonucleotide Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. China Oligonucleotide Therapeutics Market Share by Type (2015-2020)
Table 55. China Oligonucleotide Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. China Oligonucleotide Therapeutics Market Share by Application (2015-2020)
Table 57. Japan Key Players Oligonucleotide Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Oligonucleotide Therapeutics Market Share (2019-2020)
Table 59. Japan Oligonucleotide Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Oligonucleotide Therapeutics Market Share by Type (2015-2020)
Table 61. Japan Oligonucleotide Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Oligonucleotide Therapeutics Market Share by Application (2015-2020)
Table 63. Biogen Company Details
Table 64. Biogen Business Overview
Table 65. Biogen Product
Table 66. Biogen Revenue in Oligonucleotide Therapeutics Business (2015-2020) (Million US$)
Table 67. Biogen Recent Development
Table 68. Sarepta Therapeutics Company Details
Table 69. Sarepta Therapeutics Business Overview
Table 70. Sarepta Therapeutics Product
Table 71. Sarepta Therapeutics Revenue in Oligonucleotide Therapeutics Business (2015-2020) (Million US$)
Table 72. Sarepta Therapeutics Recent Development
Table 73. Jazz Pharmaceuticals Company Details
Table 74. Jazz Pharmaceuticals Business Overview
Table 75. Jazz Pharmaceuticals Product
Table 76. Jazz Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2015-2020) (Million US$)
Table 77. Jazz Pharmaceuticals Recent Development
Table 78. Bausch & Lomb Company Details
Table 79. Bausch & Lomb Business Overview
Table 80. Bausch & Lomb Product
Table 81. Bausch & Lomb Revenue in Oligonucleotide Therapeutics Business (2015-2020) (Million US$)
Table 82. Bausch & Lomb Recent Development
Table 83. Alnylam Pharmaceuticals Company Details
Table 84. Alnylam Pharmaceuticals Business Overview
Table 85. Alnylam Pharmaceuticals Product
Table 86. Alnylam Pharmaceuticals Revenue in Oligonucleotide Therapeutics Business (2015-2020) (Million US$)
Table 87. Alnylam Pharmaceuticals Recent Development
Table 88. Dynavax Technologies Company Details
Table 89. Dynavax Technologies Business Overview
Table 90. Dynavax Technologies Product
Table 91. Dynavax Technologies Revenue in Oligonucleotide Therapeutics Business (2015-2020) (Million US$)
Table 92. Dynavax Technologies Recent Development
Table 93. Kastle therapeutics Company Details
Table 94. Kastle therapeutics Business Overview
Table 95. Kastle therapeutics Product
Table 96. Kastle therapeutics Revenue in Oligonucleotide Therapeutics Business (2015-2020) (Million US$)
Table 97. Kastle therapeutics Recent Development
Table 98. Akcea Therapeutics Business Overview
Table 99. Akcea Therapeutics Product
Table 100. Akcea Therapeutics Company Details
Table 101. Akcea Therapeutics Revenue in Oligonucleotide Therapeutics Business (2015-2020) (Million US$)
Table 102. Akcea Therapeutics Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oligonucleotide Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Antisense Oligonucleotide Features
Figure 3. Aptamer Features
Figure 4. Other Features
Figure 5. Global Oligonucleotide Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Neuromuscular Diseases Case Studies
Figure 7. ATTR Case Studies
Figure 8. Hepatic VOD Case Studies
Figure 9. Other Case Studies
Figure 10. Oligonucleotide Therapeutics Report Years Considered
Figure 11. Global Oligonucleotide Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Oligonucleotide Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Oligonucleotide Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Oligonucleotide Therapeutics Market Share by Players in 2019
Figure 16. Global Top Oligonucleotide Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Oligonucleotide Therapeutics Revenue in 2019
Figure 18. North America Oligonucleotide Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Oligonucleotide Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. South America Oligonucleotide Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Oligonucleotide Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Oligonucleotide Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Biogen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Biogen Revenue Growth Rate in Oligonucleotide Therapeutics Business (2015-2020)
Figure 25. Sarepta Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Sarepta Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Business (2015-2020)
Figure 27. Jazz Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Jazz Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapeutics Business (2015-2020)
Figure 29. Bausch & Lomb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bausch & Lomb Revenue Growth Rate in Oligonucleotide Therapeutics Business (2015-2020)
Figure 31. Alnylam Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Alnylam Pharmaceuticals Revenue Growth Rate in Oligonucleotide Therapeutics Business (2015-2020)
Figure 33. Dynavax Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Dynavax Technologies Revenue Growth Rate in Oligonucleotide Therapeutics Business (2015-2020)
Figure 35. Kastle therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Kastle therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Business (2015-2020)
Figure 37. Akcea Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Akcea Therapeutics Revenue Growth Rate in Oligonucleotide Therapeutics Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Keyplayers in Global Oligonucleotide Therapeutics Market Size, Status and Forecast 2020-2026
BiogenSarepta Therapeutics
Jazz Pharmaceuticals
Bausch & Lomb
Alnylam Pharmaceuticals
Dynavax Technologies
Kastle therapeutics
Akcea Therapeutics